Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism*; D004285:Dogs; D005243:Feces / Q000032:analysis; D005965:Glucuronates / Q000378:metabolism; D006801:Humans; D008253:Macaca mulatta; D009928:Organ Specificity; D051381:Rats; D013045:Species Specificity; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005965:Glucuronates